SFI
OTLK icon

Susquehanna Fundamental Investments’s Outlook Therapeutics OTLK Stock Holding History

Susquehanna Fundamental Investments’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$303K Buy
+41,020
New +$329K 0.01% 789
2022
Q1 		– Sell
-1,532
Closed -$42K – 1652
2021
Q4 		$42K Sell
1,532
-4,023
-72% -$144K ﹤0.01% 1374
2021
Q3 		$241K Buy
+5,555
New +$268K ﹤0.01% 1478

Other funds holding OTLK

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Susquehanna Fundamental Investments's OTLK Position: Q2 2024 in Review

Susquehanna Fundamental Investments opened a new position in Outlook Therapeutics (OTLK) in Q2 2024: 41,020 shares worth $303K. The stake represents 0.01% of the portfolio and ranks #789 among its holdings. This is a return to the name: Susquehanna Fundamental Investments previously reported a position in OTLK as recently as Q4 2021.

Susquehanna Fundamental Investments first reported a position in OTLK in Q3 2021 and has held it in 3 quarters since. 64 funds tracked by Wall St. Rank hold OTLK as of Q2 2024.

  • Susquehanna Fundamental Investments held 41,020 shares of Outlook Therapeutics worth $303K as of Q2 2024.
  • Outlook Therapeutics was a new Susquehanna Fundamental Investments position in Q2 2024.
  • Outlook Therapeutics made up 0.01% of Susquehanna Fundamental Investments's portfolio in Q2 2024, its #789 holding.
  • Susquehanna Fundamental Investments first reported a position in Outlook Therapeutics in Q3 2021 and has held it in 3 quarters since.
  • 64 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2024.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2024, filed 15 Aug 2024.